Drugs / Bismuth Colloidal Pectin Granules
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04660123 | Dec 2020 → Dec 2021 | Helicobacter pylori infectious disease, gastric cancer | Xijing Hospital of Digestive Diseases | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bismuth Colloidal Pectin Granules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04660123 ↗ |
| Route | Oral | “All medication is taken orally, twice a day.” NCT04660123 ↗ |